๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

30 recruiting trials

for Cutaneous T-Cell Lymphoma/Mycosis Fungoides

Predictive and Prognostic Biomarkers in Patients With Mycosis Fungoides and Sรฉzary Syndrome. NCT04904146n/a1 site๐Ÿ“ Lund Lund University Hospital ยท Tests: Blood tests and testing of analysis of the lymphoma microenvironment in skin, skin barrier and skin microbiology profilโ€ฆ Photopheresis in Early-stage Mycosis Fungoides NCT05680558Phase 21 site๐Ÿ“ New York Columbia University ยท Tests: UVADEXยฎ (methoxsalen) Sterile Solution in conjunction with the THERAKOSยฎ CELLEX Photopheresis, THERAKOSยฎ CELLEX photophโ€ฆ A Prospective, US-based Study Assessing Mogamulizumab-associated Rash in Patients Diagnosed With Mycosis Fungoides or Sezary Syndrome and Treated With Standard of Care Mogamulizumab NCT07003100n/a10 sites๐Ÿ“ Duarte๐Ÿ“ Palo Alto๐Ÿ“ Tampa City of Hope Medical Center ยท Tests: Non-Interventional Study SKIN Disease Profiling by an Exploratory, pRospective, Biomarker Study in dermatoloGY Practice (SKINERGY) NCT07021495n/a8 sites๐Ÿ“ Nijmegen๐Ÿ“ Maastricht๐Ÿ“ Amsterdam Leiden University Medical Center A Study of Bexarotene Combined With Radiotherapy in People With Mycosis Fungoides NCT05296304Phase 13 sites๐Ÿ“ Commack๐Ÿ“ New York๐Ÿ“ Rockville Centre Memorial Sloan Kettering Cancer Center ยท Tests: Bexarotene, Total Skin Electron Beam (TSEB) JAK1 Inhibitor Golidocitnib for the Treatment of Relapsed/Refractory Indolent T/NK-cell Lymphomas NCT06716658Phase 22 sites๐Ÿ“ Tianjin๐Ÿ“ Tianjin Institute of Hematology & Blood Diseases Hospital, China ยท Tests: JAK1 Inhibitor A Study of Molecular Subtyping-based Therapeutic Strategies for Cutaneous T-cell Lymphoma NCT06436677n/a3 sites๐Ÿ“ Beijing๐Ÿ“ Beijing๐Ÿ“ Beijing Peking University First Hospital ยท Tests: molecular subtype based treatment Pembrolizumab and Mogamulizumab in Advanced-stage, Relapsed/Refractory Cutaneous T-cell Lymphomas NCT05956041Phase 21 site๐Ÿ“ Ann Arbor University of Michigan Rogel Cancer Center ยท Tests: Pembrolizumab, Mogamulizumab Phase 1 Trial of ST-001 nanoFenretinide in Relapsed/Refractory T-cell Non-Hodgkin Lymphoma NCT04234048Phase 110 sites๐Ÿ“ Scottsdale๐Ÿ“ Duarte๐Ÿ“ Los Angeles SciTech Development, Inc. ยท Tests: Fenretinide A Vaccine (VSV-hIFNฮฒ-NIS) With or Without Cyclophosphamide and Combinations of Ipilimumab, Nivolumab, and Cemiplimab in Treating Relapsed or Refractory Multiple Myeloma, Acute Myeloid Leukemia or Lymphoma NCT03017820Phase 12 sites๐Ÿ“ Scottsdale๐Ÿ“ Rochester Mayo Clinic ยท Tests: Biopsy Procedure, Biospecimen Collection, Bone Marrow Biopsy, Computed Tomography, Cyclophosphamide Intravenous Vesicular Stomatitis Virus in Patients With Peripheral T-cell Lymphoma NCT06508463Phase 12 sites๐Ÿ“ Scottsdale๐Ÿ“ Rochester Mayo Clinic ยท Tests: Biopsy, Biospecimen Collection, Bone Marrow Biopsy, Computed Tomography, Positron Emission Tomography Assessment of Safety and Efficacy of Poteligeo Inj. 20 mg (Mogamulizumab) Through Use-result Surveillance NCT07132567n/a6 sites๐Ÿ“ Busan๐Ÿ“ Seoul๐Ÿ“ Seoul Kyowa Kirin Co., Ltd. ยท Tests: Poteligeo 20mg Combining Topical Imiquimod With Local Radiotherapy for Treatment of Mycosis Fungoides NCT05838599EARLY Phase 11 site๐Ÿ“ Chicago Northwestern University ยท Tests: Imiquimod, Radiation Therapy A Phase 2 Study of PTX 100 in Patients With Relapsed/Refractory CTCL NCT06854653Phase 215 sites๐Ÿ“ Duarte๐Ÿ“ Irvine๐Ÿ“ New Haven Prescient Therapeutics, Ltd. ยท Tests: PTX-100 Study of Mogamulizumab With DA-EPOCH or CHOEP in Patients With Aggressive T-cell Lymphoma NCT05996185Phase 22 sites๐Ÿ“ New Haven๐Ÿ“ New York Yale University ยท Tests: Mogamulizumab, DA-EPOCH Protocol, CHOEP protocol Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research NCT00177268n/a1 site๐Ÿ“ Pittsburgh University of Pittsburgh ยท Tests: Blood draw, skin biopsy or urine collection A Registry for People With T-cell Lymphoma NCT05978141n/a26 sites๐Ÿ“ Duarte๐Ÿ“ San Diego๐Ÿ“ San Francisco Memorial Sloan Kettering Cancer Center ยท Tests: Optional Blood Sample and Nail Sample Long-term Outcomes Associated With Juvenile-onset Mycosis Fungoides and Lymphomatoid Papulosis NCT06207812n/a1 site๐Ÿ“ Houston M.D. Anderson Cancer Center Durvalumab With or Without Lenalidomide in Treating Patients With Relapsed or Refractory Cutaneous or Peripheral T Cell Lymphoma NCT03011814Phase 1, Phase 24 sites๐Ÿ“ Duarte๐Ÿ“ New York๐Ÿ“ Philadelphia City of Hope Medical Center ยท Tests: Durvalumab, Laboratory Biomarker Analysis, Lenalidomide A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin Lymphoma NCT07192471Phase 122 sites๐Ÿ“ Duarte๐Ÿ“ Orange๐Ÿ“ Stanford Kyowa Kirin, Inc. ยท Tests: KK2223 Dosing of Brentuximab Vedotin for Mycosis Fungoides, Sezary Syndrome Patients NCT03587844Phase 28 sites๐Ÿ“ Stanford๐Ÿ“ Basking Ridge๐Ÿ“ Middletown Memorial Sloan Kettering Cancer Center ยท Tests: brentuximab vedotin, brentuximab vedotin, brentuximab vedotin ID Of Prognostic Factors In Mycosis Fungoides/Sezary Syndrome NCT02848274n/a13 sites๐Ÿ“ Duarte๐Ÿ“ Palo Alto๐Ÿ“ Iowa City Stanford University Systemic Therapies in the Treatment of Cutaneous T-cell Lymphoma NCT06588868n/a18 sites๐Ÿ“ Ancona๐Ÿ“ Bari๐Ÿ“ Bari Fondazione Italiana Linfomi - ETS Mogamulizumab + Low-Dose Total Skin Electron Beam Tx in Mycosis Fungoides & Sรฉzary Syndrome NCT04256018Phase 21 site๐Ÿ“ Stanford Stanford University ยท Tests: Mogamulizumab, LD TSEBT Extracorporeal Photopheresis and Mogamulizumab for the Treatment of Erythrodermic Cutaneous T Cell Lymphoma NCT04930653Phase 23 sites๐Ÿ“ Scottsdale๐Ÿ“ Duarte๐Ÿ“ Atlanta City of Hope Medical Center ยท Tests: Extracorporeal Photopheresis, Mogamulizumab, Quality-of-Life Assessment, Questionnaire Administration Novel Flow-cytometry Approaches to Improve the Detection of Tumor Cells in CTCL NCT06382844n/a1 site๐Ÿ“ Salamanca Instituto de Investigaciรณn Biomรฉdica de Salamanca ยท Tests: Detection and quantitation of (blood) tumor cells in patients with mycosis fungoides (MF) / Sรฉzary syndrome (SS). Registry of Older Patients With Cancer NCT01137825n/a7 sites๐Ÿ“ Boone๐Ÿ“ Chapel Hill๐Ÿ“ Greenville UNC Lineberger Comprehensive Cancer Center Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer NCT01137643n/a1 site๐Ÿ“ Chapel Hill UNC Lineberger Comprehensive Cancer Center ยท Tests: biologic sample preservation procedure, cytology specimen collection procedure Repurposing Riluzole for Cancer-Related Cognitive Impairment: A Pilot Trial NCT06580002Phase 21 site๐Ÿ“ Orange University of California, Irvine ยท Tests: Riluzole, Placebo Effectiveness of Concurrent Ultra-Low-Dose Total-Skin Electron Beam Therapy and Brentuximab Vedotin Given Quarterly Over 12 Months for Patients With Mycosis Fungoides NCT05357794Phase 21 site๐Ÿ“ Houston M.D. Anderson Cancer Center ยท Tests: Brentuximab vedotin
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy